CAROLINA
MÉNDEZ BLANCO

PROFESOR AYUDANTE DOCTOR

Foto de CAROLINA

Foto de Complejo Asistencial Universitario de León

Complejo Asistencial Universitario de León

León, España

Publications in collaboration with researchers from Complejo Asistencial Universitario de León (5)

2024

Risk versus Benefit of Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Clinical Pharmacology and Therapeutics, Vol. 116, Núm. 2, pp. 328-345

2023

Correction to: Stabilization of Hypoxia-Inducible Factors and BNIP3 Promoter Methylation Contribute to Acquired Sorafenib Resistance in Human Hepatocarcinoma Cells (Cancers, (2019), 11, 12, (1984), 10.3390/cancers11121984)
Cancers

2019

Stabilization of hypoxia-inducible factors and BNIP3 promoter methylation contribute to acquired sorafenib resistance in human hepatocarcinoma cells
Cancers, Vol. 11, Núm. 12

2018

Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors
Experimental and Molecular Medicine, Vol. 50, Núm. 10

2017

Melatonin enhances sorafenib actions in human hepatocarcinoma cells by inhibiting mTORC1/p70S6K/HIF-1α and hypoxiamediated mitophagy
Oncotarget, Vol. 8, Núm. 53, pp. 91402-91414